| Date Filed | Type | Description |
| 08/08/2023 |
4
| Greene Barry E (President and CEO) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 195,000 options to buy
@ $85.82, valued at
$16.7M
|
|
| 05/25/2023 |
4
| Greene Barry E (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Greene Barry E (President and CEO) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 69,920 options to buy
@ $43.04, valued at
$3M
|
|
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Greene Barry E (President and CEO) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 390,000 options to buy
@ $85.82, valued at
$33.5M
|
|
| 10/22/2020 |
3
| Greene Barry E (Director) has filed a Form 3 on BCLS Acquisition Corp. |
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/11/2020 |
4
| Greene Barry E (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Gifted 3,176 shares
@ $0
Sold 14,075 shares
@ $122.66, valued at
$1.7M
Sold 27,109 shares
@ $123.39, valued at
$3.3M
Sold 3,346 shares
@ $124.38, valued at
$416.2k
Gifted 155 shares
@ $0
Gifted 3,176 shares
@ $0
Exercised 44,530 options to buy
@ $9.14, valued at
$407k
|
|
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Greene Barry E (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 15,000 options to buy
@ $0.8512, valued at
$12.8k
|
|
| 05/26/2020 |
4
| Greene Barry E (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 16,400 options to buy
@ $19.11, valued at
$313.4k
|
|
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2020 |
4
| Greene Barry E (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 5,417 shares
@ $0
Paid exercise price by delivering 1,599 shares
@ $104.75, valued at
$167.5k
Paid exercise price by delivering 64 shares
@ $106.65, valued at
$6.8k
|
|
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/26/2019 |
4
| Greene Barry E (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,999 options to buy
@ $119.13, valued at
$1.2M
|
|
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2019 |
4
| Greene Barry E (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Acquired 46 shares
@ $0
Granted 10,000 options to buy
@ $88.95, valued at
$889.5k
Granted 6,250 options to buy
@ $42.22, valued at
$263.9k
|
|
| 06/21/2019 |
4
| Greene Barry E (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 15,000 options to buy
@ $7.54, valued at
$113.1k
|
|
| 06/07/2019 |
4
| Greene Barry E (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Acquired 21 shares
@ $0
Acquired 52 shares
@ $0
Granted 6,250 options to buy
@ $42.22, valued at
$263.9k
|
|
| 06/07/2019 |
4
| Greene Barry E (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $5.43, valued at
$135.8k
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2018 |
4
| Greene Barry E (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $88.95, valued at
$889.5k
|
|
| 08/14/2018 |
4
| Greene Barry E (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Gifted 9,030 shares
@ $0
Acquired 17 shares
@ $0
Acquired 28 shares
@ $0
Acquired 29 shares
@ $0
Gifted 9,030 shares
@ $0
Granted 15,000 options to buy
@ $63, valued at
$945k
Granted 15,875 options to buy
@ $96.45, valued at
$1.5M
|
|
|